Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Holyoake

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Clinical Medicine (London, England)|May 18, 2013
The virtual bronchoscopy simulator - a young physician's viewDaniel Holyoake
Surgical Oncology|September 2, 2020
Pre- and postoperative prognostic factors for resectable esophageal adenocarcinomaPedro Serralheiro, Adeline Rankin, Allan Clark, et al.
British Journal of Cancer|July 10, 2020
Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus positionChristopher M Jones, Ganesh Radhakrishna, Katharine Aitken, et al.
British Journal of Cancer|November 3, 2020
Reply to Comment on "The UK consensus position on the treatment of pancreatic cancer during the COVID-19 pandemic"Christopher M Jones, Ganesh Radhakrishna, Katharine Aitken, et al.
European Journal of Cancer (Oxford, England : 1990)|July 26, 2024
Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trialSomnath Mukherjee, Cathy Qi, Rachel Shaw, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Clinical Medicine (London, England)|May 18, 2013
The virtual bronchoscopy simulator - a young physician's viewDaniel Holyoake
Surgical Oncology|September 2, 2020
Pre- and postoperative prognostic factors for resectable esophageal adenocarcinomaPedro Serralheiro, Adeline Rankin, Allan Clark, et al.
British Journal of Cancer|July 10, 2020
Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus positionChristopher M Jones, Ganesh Radhakrishna, Katharine Aitken, et al.
British Journal of Cancer|November 3, 2020
Reply to Comment on "The UK consensus position on the treatment of pancreatic cancer during the COVID-19 pandemic"Christopher M Jones, Ganesh Radhakrishna, Katharine Aitken, et al.
European Journal of Cancer (Oxford, England : 1990)|July 26, 2024
Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trialSomnath Mukherjee, Cathy Qi, Rachel Shaw, et al.
Pageof 1